Plasmablastic lymphoma: current perspectives
Andres Lopez,1 Pau Abrisqueta2 1Lymphoma Unit, Department of Hematology, Vall d’Hebron University Hospital, Barcelona, Spain; 2Department of Hematology, Vall d’Hebron Institute of Oncology, Vall d’Hebron University Hospital, Barcelona, Spain Abstract: Plasmablastic lymp...
Guardado en:
Autores principales: | Lopez A, Abrisqueta P |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/617ed73d97d4453bb88fd0af0a7f21e9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Current understanding of the role and regulation of miRNAs in Burkitt lymphoma
por: Videtta AD, et al.
Publicado: (2018) -
Trends in the treatment of cutaneous T-cell lymphoma – critical evaluation and perspectives on vorinostat
por: Zhang CL, et al.
Publicado: (2012) -
Developments in anaplastic large-cell lymphoma: targeting the anaplastic lymphoma kinase
por: Farina F, et al.
Publicado: (2014) -
Intrasinusoidal Hodgkin Lymphoma; A Mimic of Anaplastic Large Cell Lymphoma
por: John R. Krause, et al.
Publicado: (2021) -
MYC as therapeutic target in leukemia and lymphoma
por: Cortiguera MG, et al.
Publicado: (2015)